Menopause Review
facebook
eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Online First About the journal Editorial board Abstracting and indexing Subscription Contact Ethical standards and procedures Special Issues Instructions for authors Publication charge
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
2/2025
vol. 24
 
Share:
Send email
Share:
abstract:
Original paper

Analysis of the reasons for removal of vascular ports in patients treated in chemotherapy and gynecological oncology departments – preliminary investigations

Lidia Olszewska
1
,
Piotr Merks
2
,
Urszula Religioni
3
,
Ewa Jakubek
4, 5
,
Grażyna Jarząbek-Bielecka
6
,
Monika Englert-Golon
7
,
Witold Kędzia
8
,
Katarzyna Plagens-Rotman
6

  1. University Clinical Hospital, Poznań, Poland
  2. Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszyński University, Warszawa, Poland
  3. School of Public Health, Centre of Postgraduate Medical Education, Warszawa, Poland
  4. Department of Emergency Medicine, Faculty of Medicine and Health Sciences, Calisia University, Kalisz, Poland
  5. Department of Organization and Management in Health Care, Faculty of Health Sciences, University of Medical Sciences, Poznań, Poland
  6. Centre for Pediatric, Adolescent Gynecology and Sexology Division of Gynecology, Department of Gynecology, University of Medical Sciences, Poznań, Poland
  7. Division of Gynecological Oncology, Department of Gynecology, Gynecological Obstetric Clinical Hospital, University of Medical Sciences, Poznań, Poland
  8. Division of Gynecology, University of Medical Sciences, Poznań, Poland
Menopause Rev 2025; 24(2): 102-112
DOI: https://doi.org/10.5114/pm.2025.152126
Online publish date: 2025/06/16
View full text Get citation
 
PlumX metrics:
Introduction:
The use of vascular ports in oncology patients for the administration of irritating and chemotherapeutic drugs clearly solves the problem of peripheral vascular damage caused by oncological drugs, and at the same time provides a comfortable way of treating patients in the long term. Although there are risks associated with the long-term maintenance of implanted ports, any risk factors for infection associated with an implantable intravenous port should be minimized.

Material and methods:
The main purpose of the study was to investigate the reasons for removal of vascular ports in patients undergoing systemic treatment at the wards of the University Clinical Hospital. Patients who had a vascular port implanted for the duration of their therapy were monitored for complications that had become the reason for removing the implants within 24 months of implantation.

Results:
The main reason for removing a vascular port was the conclusion of therapy (82.7%). The second reason for removing the ports was infection (13.5%), which, despite the use of rigorous procedures, could not be avoided due to the significant reduction in immunity in patients treated with oncological drugs.

Conclusions:
Despite their limitations in oncological treatment, ports have no alternatives, and thus further technological progress is essential. Education of staff working with patients with implants allows an increase in the benefits of therapy in the long run and significantly improves the quality of life of oncological patients. The education of patients and their families, as well as frequent re-training of staff, provides greater opportunities to minimize the side effects of therapy and reduce the number of adverse reactions related to infections.

keywords:

vascular port, infections, chemotherapy

Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2026 Termedia Sp. z o.o.
Developed by Termedia.